TNF and myasthenia gravis: Conflicting results have been reported regarding the use of the TNF-α-inhibiting molecule, Enbrel® (etanercept, Benepali, Erelzi; Amgen, Thousand Oaks, CA, USA), and anti-TNF-α mAb treatment in MG and preclinical models.